| BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]- |
ALW-II-41-27 |
1186206-79-0 |
| RAD140 |
RAD-140 |
1182367-47-0 |
| Suvorexant |
苏沃雷生 |
1030377-33-3 |
| TG4-155 |
TG4-155; TG-4-155; TG 4-155; TG4155; TG-4155; TG 4155 |
1164462-05-8 |
| IOX4 |
TERT-BUTYL 6-(5-OXO-4-(1H-1,2,3-TRIAZOL-1-YL)-2,5-DIHYDRO-1H-PYRAZOL-1-YL)NICOTINATE |
1154097-71-8 |
| BBI-608 |
1134099-70-9 |
1134099-70-9 |
| BBI-503(BB-503) |
AMCASERTIB |
1129403-56-0 |
| GSK1838705A |
GSK1838705A |
1116235-97-2 |
| 4-Quinazolinamine, N-cyclohexyl-2-cyclopropyl- |
化合物TH1085 |
1002801-51-5 |
| NADA |
NADA |
199875-69-9 |
| 5-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamine |
5-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamine |
1026582-88-6 |
| CC-122 |
3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4H)-基)哌啶-2,6-二酮 |
1015474-32-4 |
| CARBAMIC ACID, N-[2-[(R)-(3-CHLOROPHENYL)[(3R)-1-[[[(2S)-2-(METHYLAMINO)-3-[(3R)-TETRAHYDRO-2H-PYRAN-3-YL]PROPYL]AMINO]CARBONYL]-3-PIPERIDINYL]METHOXY]ETHYL]-, METHYL ESTER, 2,2,2-TRIFLUOROACETATE (1:1) |
N-[2-[(R)-(3-氯苯基)[(3R)-1-[[[(2S)-2-(甲基氨基)-3-[(3R)-四氢-2H-吡喃-3-基]丙基]氨基]羰基]-3-哌啶基]甲氧基]乙基]氨基甲酸甲酯 2,2,2-三氟乙酸盐 |
1013937-63-7 |
| N-[3-FLUORO-5-(3-PYRINDYL)PHENYL]-2,3-DIHYDRO-5-METHOXY-6-(TRIFLUOROMETHYL)-1H-INDOLE-1-CARBOXAMIDE |
SB228357 |
181629-93-6 |
| Trastuzumab |
曲妥珠单抗 |
180288-69-1 |
| BV6 |
BV 6 |
1001600-56-1 |
| AP20187 |
AP 20187 |
195514-80-8 |
| 1-(4-IODOPHENYL)-3-(2-ADAMANTYL)GUANIDINE |
化合物 T22870 |
193527-91-2 |
| SR 144528 |
192703-06-3 |
192703-06-3 |
| N-[6-(2,6-Dichlorophenyl)-2-[[4-(diethylamino)butyl]amino]pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea |
PD-161570;PF-1480232 |
192705-80-9 |
